Cargando…
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
Reports on the prognostic role of programmed death-ligand 1 (PD-L1) expression in rectal cancer are controversial. We investigated expression patterns and changes of PD-L1 in rectal cancer patients undergoing neoadjuvant chemoradiotherapy (CRT). Seventy-two patients diagnosed with rectal cancer and/...
Autores principales: | Huemer, Florian, Klieser, Eckhard, Neureiter, Daniel, Schlintl, Verena, Rinnerthaler, Gabriel, Pagès, Franck, Kirilovsky, Amos, El Sissy, Carine, Iglseder, Wolfgang, Singhartinger, Franz, Jäger, Tarkan, Dinnewitzer, Adam, Zaborsky, Nadja, Steiner, Markus, Greil, Richard, Weiss, Lukas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563312/ https://www.ncbi.nlm.nih.gov/pubmed/32867256 http://dx.doi.org/10.3390/jcm9092775 |
Ejemplares similares
-
The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer
por: Jäger, Tarkan, et al.
Publicado: (2018) -
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies
por: Magnes, Teresa, et al.
Publicado: (2021) -
How We Treat Localized Rectal Cancer—An Institutional Paradigm for Total Neoadjuvant Therapy
por: Roeder, Falk, et al.
Publicado: (2022) -
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence
por: Magnes, T., et al.
Publicado: (2021) -
Nonmetastatic pancreatic cancer: Improved survival with chemoradiotherapy > 40 Gy after systemic treatment
por: Bachmayer, Sebastian, et al.
Publicado: (2018)